Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

GOP sadism proudly on display

The abortion pill decision proves, yet again, that there's nothing "pro-life" about Republicans

Salon

Legal fight over abortion drug could quickly hit Supreme Court

WASHINGTON — The Justice Department and several Democrat-led states took steps Monday to preserve access to a commonly used medication abortion drug after dueling federal court rulings about its availability.

Tribune News Service

2 Biotech Stocks That Are Screaming “SELL ME!”

The biotech sector is witnessing the headwinds from the banking crisis, layoffs, and the Inflation Reduction Act. So, fundamentally weak biotech stocks Ginkgo Bioworks Holdings (DNA) and Novavax (NVAX) might be best avoided. Read on.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Cancer and heart disease vaccines could be ready 'by the end of the decade'

The speed of which the Covid jab was developed has "unspooled" medical advancements

Wales Online

Abortion pill case: where does the lawsuit against the pill currently stand?

The fifth circuit court of appeals is considering the future of mifepristone after the supreme court blocked new restrictions

The Guardian - US

FDA approval of abortion pill suspended

Biden has one week to appeal

Salon

Federal judge in Texas suspends FDA approval of abortion pill

The ruling from U.S. District Judge Matthew Kacsmaryk in Amarillo could potentially upend access to medication abortion nationwide.

The Texas Tribune

Read news from The Economist, FT, and more,
with one subscription

Details of Geraldton drug bust, then Australia's biggest meth seizure, can finally be revealed

After more than five years, three trials and countless hours of legal argument, details can finally be revealed of the brazen attempt to import 1.2 tonnes of meth into Western Australia.

ABC News

3 'A-Rated' Pharmaceutical Stocks UNDER $15 to Own in April

The pharmaceutical industry is positioned for considerable growth in the upcoming years, thanks to increased demand, investments in research and development, and the expansion of e-pharmacy channels. Therefore, A-rated pharmaceutical stocks Astellas Pharma (ALPMY), Ono Pharmaceutical (OPHLY), and Santen Pharmaceutical (SNPHY), trading under $15, could be worth owning in April.…

StockNews.com

FDA pulls the only approved drug for preventing premature birth off the market

The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.

WEKU

FDA forces unproven premature birth drug Makena off market

The Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market

The Independent UK

NI Community pharmacies to be reduced as DoH issues statement

"These actions have the potential to impact on patients and other parts of the Health and Social Care system"

Belfast Live

10 questions for Ivan Hollingsworth of Centric Consultants

The fundraiser and now entrepreneur answers our questions

Birmingham Post

High profile Tyneside fundraiser launches new business Centric Consultants

Ivan Hollingsworth and his wife Nadine launched the new business on moves to tackle ‘culture-washing’

Birmingham Post

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

FDA approval of Narcan as over-the-counter drug will boost accessibility, save lives, health officials say

BALTIMORE — As soon as this summer, people will be able to purchase the opioid overdose reversal medication Narcan as easily as they can buy Tylenol and Benadryl, after the U.S. Food and Drug Administration approved it last week to be sold over the counter.

Chicago Sun-Times

How Illinois has taken steps to lower prescription drug prices

In only four states do residents spend more on drugs than the Land of Lincoln. The health care industry faces a monopoly problem, not a market problem

The Independent UK

Eyedrops maker couldn't ensure factory was sterile, FDA says

The Food and Drug Administration says it found a host of problems at an Indian manufacturing plant recently linked to contaminated eyedrops

Reuters

Exclusive-Germany's Stada asks Berlin to help secure its future in Ukraine

Generic drugmaker Stada has asked the German government to seek assurances from Ukraine that the company can continue operations there even though it also does business in Russia, according to a letter seen by Reuters.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 in-Demand Consumer Goods Stocks

Although fears of a recession are still widespread, the consumer products industry could benefit from consumers displaying resilience in the face of high inflation. Thus, investing in quality consumer goods stocks USANA Health (USNA), Nature's Sunshine (NATR), and LifeVantage (LFVN) could be beneficial. Read on….

Tribune News Service

San Jose police union office manager charged with importing, distributing fentanyl

SAN JOSE, Calif. – A longtime office manager for the San Jose Police Officers Association allegedly used her work computer to order controlled substances from abroad, including an analog version of fentanyl, and distributed the drugs from her office, according to a federal criminal complaint.

The Guardian - UK

Unstable review – this Rob Lowe nepo-sitcom is staggeringly joke-free

The actor stars alongside his son (playing his son) in a nauseatingly schmaltzy, second-tier comedy. It’s utterly unfunny, but at least its lead is as charming as ever

Al Jazeera

US approves sale of overdose reversal drug without prescription

The decision comes as a bid to widen access to the life-saving drug as the US struggles with a wave of overdose deaths.

StockNews.com

Stay Forever Young With These 3 Pharmaceutical Stocks

Despite macroeconomic headwinds, the pharmaceutical industry is anticipated to stay buoyed in the foreseeable future, owing to rising healthcare spending. Against this backdrop, we think the strong fundamentals of Novo Nordisk (NVO), Bristol-Myers Squibb (BMY), and Takeda Pharmaceutical (TAK) make them wise portfolio additions. Read on….

Birmingham Post

Quotient Sciences creates 100 new jobs fresh from multimillion-pound plant expansion

Recent expansion created an additional 80 to 100 new scientific and technical jobs at the facility - and now more have been created

StockNews.com

3 of the Best Stocks in 1 of Wall Street's Worst-Rated Industry

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…

1 … 54 55 56 57

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Food and Drug Administration

336 stories

GILD

211 stories

the Food and Drug Administration

207 stories

Australian Federal Police

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.